4Dmedical, AU0000095416

4DMedical stock: Former ResMed CFO joins board

Published on 11/17/2026 at 20:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
4DMedical stock gets a new independent director as Brett Sandercock takes charge of the audit committee. He joins after 27 years at ResMed.

Board oversight and expansion

  • Brett Sandercock joins 4DMedical as an independent non-executive director effective November 16, 2026.
  • He will chair the Audit and Risk Committee and stand for election at the next annual general meeting.
  • His background includes 27 years at ResMed, including 20 years as chief financial officer.
4Dmedical, AU0000095416, Illustration mit AI erstellt.

4DMedical has appointed former ResMed chief financial officer Brett Sandercock as an independent non-executive director, effective November 16, 2026. The appointment was announced in an ASX announcement carried by Listcorp.

New director takes audit chair

Sandercock will chair 4DMedical's Audit and Risk Committee and join the Remuneration and Nomination Committee. He will stand for election at the company's next annual general meeting.

Sandercock spent 27 years at ResMed, including 20 years as chief financial officer from 2006 until his retirement in May 2026. His experience includes capital allocation, investor relations, mergers and acquisitions, risk management and international expansion.

4DMedical executive chair Julian Sutton said the appointment adds financial, audit and governance experience. Chief executive Andreas Fouras said Sandercock's background is relevant as the company scales its CT:VQ technology across the United States and Europe and integrates recent acquisitions.

Current European trading quote

4DMedical stock traded at 1.31 euros on Lang & Schwarz at 20:29 CET on Tuesday, November 17, 2026.

4DMedical Limited at a glance

  • Company: 4DMedical Limited
  • ISIN: AU0000095416
  • ASX ticker: 4DX
  • Home exchange: Australian Securities Exchange
  • Lang & Schwarz quote: 1.31 euros at 20:29 CET on November 17, 2026

The broader Australian market is represented by the S&P/ASX 200.

More news and analyses on 4DMedical stock

Disclaimer...
en | AU0000095416 | 4DMEDICAL | boerse | 70528519 | bgmi